Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

Eviva Partners Launches New Think Tank, Exposes Attack on Aluminum-Containing Vaccines
  • USA - Deutsch
  • USA - Français
  • USA - Polski
  • USA - español
  • USA - čeština
  • USA - Pусский
  • USA - slovenčina
  • Japan - Japanese
  • Indonesia - Bahasa
  • Middle East - Arabic
  • Korea - 한국어
  • MEXICO - Spanish
  • BRAZIL - Portuguese
  • APAC - Traditional Chinese
  • USA - English
  • APAC - English


News provided by

Eviva Partners

30 Jul, 2025, 21:36 IDT

Share this article

Share toX

Share this article

Share toX

NEW YORK, July 30, 2025 /PRNewswire/ -- Eviva Partners, a nonprofit organization dedicated to strengthening public understanding of medical evidence, is proud to announce the launch of Protecting Our Health (POH), a new think tank that brings together international experts in communication, public health and misinformation to confront the rise of pseudoscience.

"Medical research has generated a tremendous number of evidence-based interventions, but these are not universally adopted, leading to gaps in care," said Eviva CEO and founder Alex Morozov, a physician-scientist, writer and former pharmaceutical executive. "Our goal is to empower people to make evidence-based decisions. This is more important now than ever. POH was launched to counteract the assault on science and health — and to reach people before deceptive tactics take hold."

Eviva and POH are grounded in three principles:

  • Bringing the public back to science: POH aims to empower individuals to distinguish solid medical evidence from pseudoscience.
  • Inclusion: Understanding the needs of diverse communities and empowering them through evidence and two-way communication.
  • No industry funding, ever: Eviva is currently self-funded and is building a coalition of philanthropists.

On Sunday, MSNBC published an op-ed by Morozov, leading vaccinologist Dr. Helen Petousis-Harris and Eviva board member Professor Stephan Lewandowsky.

"Robert F. Kennedy Jr. and others … appear to be orchestrating a strategic attack on aluminum-containing vaccines," the op-ed says.

But the science does not support aluminum as the culprit. In a major new study involving more than 1.2 million children, Danish researchers found no link between aluminum in vaccines and 50 chronic diseases, including autism.

The op-ed warns: "If anti-vaccine activists successfully undermine aluminum-containing vaccines despite research findings like the Danish study, the consequences will be catastrophic. Vaccine-preventable diseases — such as diphtheria, meningitis, hepatitis and cancers of the liver, cervix and penis — will bounce back, causing tremendous death and suffering. And rates of autism will remain unchanged, as they have for decades."

Protecting Our Health is not just a campaign. It is a call to action. By combining evidence, storytelling and community engagement, Eviva and POH seek to undo the damage caused by misinformation and chart a path forward — one rooted in evidence, empowerment and health for all.

To learn more or to support the campaign, visit www.evivapartners.org.

Modal title

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.